Marksans Pharma acquires Teva's manufacturing site in GoaThe manufacturing site is spread across 47,597 sq meters and has approvals to manufacture products from EU, Health Canada and Japanese Heal...
12 Oct, 2022, 12.03 AM IST
DRL's foray into medical cannabis to prompt others' entryIn December, global drug major Pfizer announced its acquisition of Arena Pharma, a medical cannabis company, for $6.7 billion. In May last ...
10 Feb, 2022, 08.25 AM IST
New toxic drug impurities detected in some heart pills in USThe impurities were found in blood pressure drugs which have been recalled in Canada as well as Europe earlier this year. U.S. officials he...
13 Oct, 2021, 10.26 PM IST
What spooked Sun Pharma stock in Monday’s tradeA total of 93 per cent of revenue of Sun Pharma’s US unit comes from US operations.
13 May, 2019, 06.39 PM IST
DRL, IPCA Laboratories products come under Canadian government scannerFDA recently pointed out as many as 9 procedural deviations in manufacturing plant belonging to Dr Reddy's Laboratories in Srikakulam distr...
24 Dec, 2014, 05.59 PM IST
Venus Remedies ties up with Israel's Teva for anti-cancer drugChandigarh based Pharma major has entered into agreement with Israel-based generic drug maker Teva to sell anti- cancer drug in Canadian ma...
26 Aug, 2014, 05.40 PM IST
Sun Pharma-Ranbaxy deal: We will guide Ranbaxy, says Dilip ShanghviShanghvi started his entrepreneurial dreams with a loan of Rs 10,000 from his father. It’s that same instinct that’s needed at Ranbaxy now,...
09 Apr, 2014, 08.04 AM IST
- Natco inks agreement with Mylan for Copaxone
Home grown major Natco Pharma today said it has signed a licence and supply agreement with US-based Mylan for the global sale of generic ve...
10 Jun, 2008, 08.38 PM IST
- Here's someone who bet on India 12 years back
His UK colleagues were bemused by his choice, but Brian Tempest saw big potential in India.
15 Dec, 2007, 03.39 AM IST
- Lupin wins Altace patent case in US
India’s Lupin has won its patent challenge against King Pharmaceuticals and Sanofi-Aventis for blood pressure drug Altace, which has sales ...
13 Sep, 2007, 05.19 AM IST
- Glenmark gets nod to sell Zofran generic in US
Glenmark Pharmaceuticals has received final approval to market a generic version of GlaxoSmithKline’s popular anti-emetic drug Zofran, that...
30 Jun, 2007, 02.44 AM IST
- Indian drug cos prepare a peptide mix
As blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...
14 Jun, 2007, 01.49 AM IST
- Cipla, PEs team up for Merck's biz
Ranbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
16 Mar, 2007, 02.08 AM IST
- Merck Generics valuation to be hit as Duoneb patent ends
Merck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for...
02 Mar, 2007, 12.43 AM IST
- Local cos line up for Merck unit
The bidding process for the generics business of German pharmaceutical corporation Merck is set to begin in a few days. The advisors to Mer...
06 Feb, 2007, 12.24 AM IST
- Cos exit generics for core focus
As international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
10 Jan, 2007, 12.39 AM IST
- Ranbaxy may pop Merck pill
Ranbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.
09 Jan, 2007, 01.56 AM IST